Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order for Senior Postdoctoral Research Scientist Dr Joaquim Miguel Vieira, who was been awarded an Intermediate Fellowship from the British Heart Foundation. This award will fund research designed to better understand the basic mechanisms behind cardiovascular development and could pave the way for innovative treatments of heart disease.

Joey VieiraDr Joaquim Vieira, a Senior Postdoctoral Research Scientist in Professor Paul Riley’s team, has been awarded a BHF Intermediate Basic Science Research Fellowship for his research “Investigating the functional role of the noncoding genome during epithelial-to-mesenchymal transition to enable cardiovascular regeneration." 

A heart attack occurs when blood flow to a large portion of the heart decreases or stops, causing damage to the heart muscle. Nearly one billion of muscle cells are permanently lost after such event and replaced by non-contractile scar tissue in a process called fibrosis that further compromises the function of the heart and ultimately, leads to heart failure. To date, no treatment has been effective in mending the heart following a heart attack.

In recent work here at DPAG, Dr Vieira has demonstrated that the heart attempts to replenish its damaged tissue by reverting to similar processes that were used in the embryo to build the heart before birth:

 

In particular, cells from the outer layer of the heart, the epicardium, become activated in a process called epithelial-to-mesenchymal transition (EMT), but this activation is transient and insufficient to support new blood vessel and muscle growth as it happens in the embryo, instead activated epicardial cells in the adult heart support the process of fibrosis. I propose that understanding the process of EMT in greater detail will enable the development of better drugs to stimulate the heart to repair itself more efficiently after a heart attack - Dr Joaquim Vieira

The award from the BHF will fund a five-year basic science project designed to functionally explore the yet poorly understood role of non-coding RNAs in the regulation of epithelial-to-mesenchymal transition (EMT) during heart development.

The aim is to achieve a better understanding of EMT and its regulatory mechanisms to enable novel therapeutic approaches for heart disease.

I am very grateful to the British Heart Foundation for sponsoring me for the next five years. This is an exciting opportunity for developing my research on understanding the basic cellular and molecular mechanisms regulating cardiovascular development, as an independent scientist working in a world-class environment. It is my belief that the knowledge arising from this study will enable the development of innovative and effective treatments for cardiovascular disease - Dr Joaquim Vieira

More information on the BHF Intermediate Basic Science Fellowship is available here.

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Professor Dame Frances Ashcroft to receive Vanderbilt Prize in Biomedical Science

The Vanderbilt Prize in Biomedical Science recognises women scientists with a stellar record of research accomplishments who also have made significant contributions to mentoring other women in science.

Annie Park to advance our understanding of how the brain encodes reward with new Wellcome Trust Award

Congratulations are in order for Postdoctoral Fellow Dr Annie Park who has been awarded a prestigious Wellcome Early-Career Award.

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.